54226-20-9 Suppliers

Recommended suppliersmore

54226-20-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 54226-20-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,4,2,2 and 6 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 54226-20:
(7*5)+(6*4)+(5*2)+(4*2)+(3*6)+(2*2)+(1*0)=99
99 % 10 = 9
So 54226-20-9 is a valid CAS Registry Number.

54226-20-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name	4-amino-3,5-dinitro-benzoic acid methyl ester

1.2 Other means of identification

Product number	-
Other names	4-Amino-3,5-dinitro-benzoic acid methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses	For industry use only.
Uses advised against	no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number	-
Service hours	Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:54226-20-9 SDS

54226-20-9Upstream product

54226-20-9Downstream Products

54226-23-2 methyl 3,4-diamino-5-nitrobenzoate

54226-20-9Relevant articles and documents

Second generation of BACE-1 inhibitors. Part 1: The need for improved pharmacokinetics

Charrier, Nicolas,Clarke, Brian,Cutler, Leanne,Demont, Emmanuel,Dingwall, Colin,Dunsdon, Rachel,Hawkins, Julie,Howes, Colin,Hubbard, Julia,Hussain, Ishrut,Maile, Graham,Matico, Rosalie,Mosley, Julie,Naylor, Alan,O'Brien, Alistair,Redshaw, Sally,Rowland, Paul,Soleil, Virginie,Smith, Kathrine J.,Sweitzer, Sharon,Theobald, Pam,Vesey, David,Walter, Daryl S.,Wayne, Gareth

scheme or table, p. 3664 - 3668 (2010/03/24)

Inhibition of the aspartyl protease BACE-1 has the potential to deliver a disease-modifying therapy for Alzheimer's disease. We have recently disclosed a series of transition-state mimetic BACE-1 inhibitors showing nanomolar potency in cell-based assays.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 54226-20-9

CAS

54226-20-9